Ramucirumab

CAS No. 947687-13-0

Ramucirumab( —— )

Catalog No. M30048 CAS No. 947687-13-0

Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors,is also a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 511 In Stock
10MG 738 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ramucirumab
  • Note
    Research use only, not for human use.
  • Brief Description
    Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors,is also a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors.
  • Description
    Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors,is also a fully human monoclonal antibody (IgG1) developed for the treatment of solid tumors.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    947687-13-0
  • Formula Weight
    6369.07
  • Molecular Formula
    C285H434N74O88S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Probimane

    Probimane had Anti-proliferative effects, cell cycle G2/M phase arrest and blocking of chromosome segregation in human tumor cell lines with MST-16.

  • Eslicarbazepine Acet...

    Eslicarbazepine acetate is an antiepileptic drug.

  • Mulberrofuran Q

    Mulberrofuran Q is an active compound that inhibits the formation of 12-hydroxy-5,8,10-heptadecatrienoic acid (HHT) and thromboxane B2 (cyclooxygenase product) , which protects neuronal cells from hypoxia-glycorrhoea-deficiency (OGD)-induced oxidative stress.